Skip to main content
OpenTrials

Clinical trial condition

Alkylating Agent-Related Acute Myeloid Leukemia

Explore clinical trials studying Alkylating Agent-Related Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

14 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Alkylating Agent-Related Acute Myeloid Leukemia trial results

Active, not recruiting

Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia

NCT01627041

Conditions
Acute Myeloid Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Monoblastic Leukemia, +17 more
Locations
  • Lafayette Family Cancer Center-EMMC Brewer, Maine, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

NCT00093470

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monocytic Leukemia, +31 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Kaiser Permanente-San Diego Mission San Diego, California, United States
View all 341 locations
View Trial Details
Completed

Veliparib and Temozolomide in Treating Patients With Acute Leukemia

NCT01139970

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +45 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia

NCT01168219

Conditions
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, +34 more
Locations
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 17 locations
View Trial Details
Completed

Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia

NCT01307579

Conditions
Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +42 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 179 locations
View Trial Details
Completed

Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

NCT00313586

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, +28 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Los Angeles Oncology Institute Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
View all 234 locations
View Trial Details

Related conditions